MedTrace Logo

Collagenase in the Treatment of Cellulite

NCT00261144 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-12-12

No results posted yet for this study

Summary

The purpose of this study is to determine if collagenase injection will reduce or eliminate the appearance of cellulite of the thigh.

Conditions

  • Cellulite

Interventions

DRUG

Collagenase

One 0.58mg injection every two weeks for six weeks (total three 0.58mg injections)

BIOLOGICAL

Biological

Collagenase injection

Sponsors & Collaborators

Principal Investigators

  • Marie A Badalamente, PhD · Dept. Orthopaedics, SUNY@Stony Brook, NY 11794

  • Alexander B Dagum, MD · Dept. Surgery, SUNY@Stony Brook, NY 11794

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-02-28
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00261144 on ClinicalTrials.gov